Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 2/20 | 0.32 |
| ▸ | FPR1 | P21462 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | XIAP | P98170 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30767408 | 1.00 | F10 (0.32) | F10FPR2FPR1CNR1CNR2 | |
| SCHEMBL30767676 | 1.00 | F10 (0.32) | F10FPR2FPR1CNR1CNR2 | |
| SCHEMBL30767526 | 0.94 | GPR119 (0.31) | — | |
| SCHEMBL30767423 | 0.94 | GPR119 (0.31) | — | |
| SCHEMBL30767405 | 0.94 | GPR119 (0.31) | — | |
| SCHEMBL30767477 | 0.93 | F10 (0.33) | F10FPR2FPR1CNR1CNR2 | |
| SCHEMBL30767579 | 0.93 | MDM2 (0.33) | FPR2 | |
| SCHEMBL30767484 | 0.93 | MDM2 (0.33) | FPR2 | |
| SCHEMBL30767584 | 0.93 | MDM2 (0.33) | FPR2 | |
| SCHEMBL30767542 | 0.92 | NPY1R (0.33) | XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568960-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024033458-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-15 | — | — | WO | disclosed |